Jason Rotter

821 total citations
29 papers, 553 citations indexed

About

Jason Rotter is a scholar working on Economics and Econometrics, Oncology and General Health Professions. According to data from OpenAlex, Jason Rotter has authored 29 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 10 papers in Oncology and 7 papers in General Health Professions. Recurrent topics in Jason Rotter's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Economic and Financial Impacts of Cancer (10 papers) and Multiple and Secondary Primary Cancers (4 papers). Jason Rotter is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Economic and Financial Impacts of Cancer (10 papers) and Multiple and Secondary Primary Cancers (4 papers). Jason Rotter collaborates with scholars based in United States, South Africa and United Kingdom. Jason Rotter's co-authors include Stephanie B. Wheeler, Alex K. Gertner, Jennifer C. Spencer, Paul Shafer, Corey S. Davis, Melinda M. Davis, Robin C. Vanderpool, Brian J. Piper, Whitney E. Zahnd and Linda K. Ko and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jason Rotter

28 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Rotter United States 12 200 167 139 130 73 29 553
Lih‐Wen Mau United States 14 111 0.6× 154 0.9× 93 0.7× 180 1.4× 105 1.4× 47 731
Shellie D. Ellis United States 14 119 0.6× 189 1.1× 86 0.6× 170 1.3× 36 0.5× 51 650
Thomas Keeley United Kingdom 14 266 1.3× 194 1.2× 75 0.5× 181 1.4× 33 0.5× 20 655
Tisha M. Felder United States 17 116 0.6× 293 1.8× 171 1.2× 223 1.7× 53 0.7× 47 679
Robin L. Whitney United States 11 74 0.4× 153 0.9× 114 0.8× 136 1.0× 44 0.6× 34 444
Sawitri S. Sadarjoen Indonesia 13 209 1.0× 192 1.1× 189 1.4× 60 0.5× 34 0.5× 19 659
Jeanne M. Regnante United States 3 181 0.9× 191 1.1× 69 0.5× 262 2.0× 48 0.7× 6 630
Michelle A. Lampman United States 13 114 0.6× 334 2.0× 117 0.8× 116 0.9× 60 0.8× 38 631
Daniel Gilden United States 12 166 0.8× 189 1.1× 59 0.4× 168 1.3× 45 0.6× 23 699
Thanya Pathirana Australia 10 177 0.9× 233 1.4× 155 1.1× 80 0.6× 138 1.9× 21 720

Countries citing papers authored by Jason Rotter

Since Specialization
Citations

This map shows the geographic impact of Jason Rotter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Rotter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Rotter more than expected).

Fields of papers citing papers by Jason Rotter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Rotter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Rotter. The network helps show where Jason Rotter may publish in the future.

Co-authorship network of co-authors of Jason Rotter

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Rotter. A scholar is included among the top collaborators of Jason Rotter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Rotter. Jason Rotter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rotter, Jason, et al.. (2024). Markets matter: a simulation study of the bias-variance trade-off in comparison group selection for difference-in-differences analysis. Health Services and Outcomes Research Methodology. 25(2). 166–181.
2.
Kaufman, Brystana G., Jason Rotter, Sally C. Stearns, et al.. (2022). Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study. BMJ Open. 12(11). e058777–e058777. 13 indexed citations
3.
Reeder‐Hayes, Katherine E., Stephanie B. Wheeler, Anne Meyer, et al.. (2021). Adoption and effectiveness of de-escalated radiation and endocrine therapy strategies for older women with low-risk breast cancer. Journal of Geriatric Oncology. 12(5). 731–740. 3 indexed citations
4.
Gertner, Alex K., et al.. (2021). The Role of Primary Care in the Initiation of Opioid Use Disorder Treatment in Statewide Public and Private Insurance. Journal of Addiction Medicine. 16(2). 183–191. 4 indexed citations
5.
Rotter, Jason, et al.. (2021). Woody hardness classification impact on salvage laryngectomy functional outcomes. American Journal of Otolaryngology. 42(3). 102877–102877. 2 indexed citations
6.
Wheeler, Stephanie B., Jason Rotter, Christopher D. Baggett, et al.. (2021). Cost-effectiveness of endocrine therapy versus radiotherapy versus combined endocrine and radiotherapy for older women with early-stage breast cancer. Journal of Geriatric Oncology. 12(5). 741–748. 5 indexed citations
7.
Biddell, Caitlin B., Lisa P. Spees, Deborah K. Mayer, et al.. (2020). Developing personalized survivorship care pathways in the United States: Existing resources and remaining challenges. Cancer. 127(7). 997–1004. 2 indexed citations
8.
Trogdon, Justin G., Christopher D. Baggett, Katherine E. Reeder‐Hayes, et al.. (2020). Medical costs associated with metastatic breast cancer in younger, midlife, and older women. Breast Cancer Research and Treatment. 181(3). 653–665. 23 indexed citations
9.
Wilson, Lauren E., Melissa A. Greiner, Ivy Altomare, Jason Rotter, & Michaela A. Dinan. (2020). Rapid rise in the cost of targeted cancer therapies for Medicare patients with solid tumors from 2006 to 2015. Journal of Geriatric Oncology. 12(3). 375–380. 8 indexed citations
10.
Rotter, Jason, Hung‐Jui Tan, Erin E. Kent, et al.. (2020). The association between patient experience and healthcare outcomes using SEER-CAHPS patient experience and outcomes among cancer survivors. Journal of Geriatric Oncology. 12(4). 623–631. 8 indexed citations
11.
Rotter, Jason, Lauren E. Wilson, Melissa A. Greiner, Craig Evan Pollack, & Michaela A. Dinan. (2019). Shared-patient physician networks and their impact on the uptake of genomic testing in breast cancer. Breast Cancer Research and Treatment. 176(2). 445–451. 5 indexed citations
12.
Rotter, Jason, Justin G. Trogdon, Ke Meng, et al.. (2019). An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer. Breast Cancer Research and Treatment. 174(2). 343–355. 11 indexed citations
13.
Gertner, Alex K., Jason Rotter, & Paul Shafer. (2019). Association Between State Minimum Wages and Suicide Rates in the U.S.. American Journal of Preventive Medicine. 56(5). 648–654. 69 indexed citations
14.
Zahnd, Whitney E., Melinda M. Davis, Jason Rotter, et al.. (2019). Rural-urban differences in financial burden among cancer survivors: an analysis of a nationally representative survey. Supportive Care in Cancer. 27(12). 4779–4786. 70 indexed citations
15.
Spencer, Jennifer C., Stephanie B. Wheeler, Jason Rotter, & Mark Holmes. (2018). Decomposing Mortality Disparities in Urban and Rural U.S. Counties. Health Services Research. 53(6). 4310–4331. 37 indexed citations
16.
Wheeler, Stephanie B., Jennifer C. Spencer, & Jason Rotter. (2018). Toward Value in Health Care. North Carolina Medical Journal. 79(1). 62–65. 10 indexed citations
17.
Fleurence, Rachael, Laura P. Forsythe, Michael S. Lauer, et al.. (2014). Engaging Patients and Stakeholders in Research Proposal Review: The Patient-Centered Outcomes Research Institute. Annals of Internal Medicine. 161(2). 122–130. 55 indexed citations
18.
Delea, Thomas E., et al.. (2012). Cost-Effectiveness of Zoledronic Acid Compared with Clodronate in Multiple Myeloma. Current Oncology. 19(6). 392–403. 9 indexed citations
19.
Rotter, Jason, et al.. (2012). The changing role of economic evaluation in valuing medical technologies. Expert Review of Pharmacoeconomics & Outcomes Research. 12(6). 711–723. 16 indexed citations
20.
Delea, Thomas E., Jason Rotter, Matthew Taylor, et al.. (2012). Cost-effectiveness of zoledronic acid vs clodronic acid for newly-diagnosed multiple myeloma from the United Kingdom healthcare system perspective. Journal of Medical Economics. 15(3). 454–464. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026